Nikovari Bio Tech

Nikovari is a pre-clinical stage biotechnology company focused on developing next-generation gene regulation therapies for difficult-to-treat cancers. The company utilizes a proprietary platform designed to achieve precise control over gene expression, specifically targeting oncogenic drivers like KRAS that have historically been challenging to inhibit effectively. By combining advanced molecular biology with computational design, Nikovari aims to create highly selective therapeutics that minimize off-target effects while maximizing anti-tumor activity. Their lead programs are currently focused on solid tumors with high unmet medical needs.